# Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes

Study · id `cardio:ct-nct05569772` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05569772](<https://clinicaltrials.gov/study/NCT05569772>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05569772

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 252 participants.

## Technical summary

Registry record NCT05569772. Randomized; triple masking; primary purpose prevention. Start 2023-09-14 (actual); primary completion 2030-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 252 participants (planned count; ClinicalTrials.gov record NCT05569772, source copy `cardio:ctgov-nct05569772-2026-09-15`, retrieved 2026-10-26)
- Started: 2023-09-14 (actual) (ClinicalTrials.gov record NCT05569772, source copy `cardio:ctgov-nct05569772-2026-09-15`, retrieved 2026-10-26)
- Primary completion: 2030-03 (anticipated) (ClinicalTrials.gov record NCT05569772, source copy `cardio:ctgov-nct05569772-2026-09-15`, retrieved 2026-10-26)
- Completion: 2030-05 (anticipated) (ClinicalTrials.gov record NCT05569772, source copy `cardio:ctgov-nct05569772-2026-09-15`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT05569772, source copy `cardio:ctgov-nct05569772-2026-09-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05569772-2026-09-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
- Acronym: SERENA
- Condition: Glucose Intolerance After a Recent History of Gestational Diabetes
- Intervention (Drug): Semaglutide Pen Injector
- Intervention (Drug): Semaglutide placebo
- Lead sponsor: Universitaire Ziekenhuizen KU Leuven
- Lead sponsor class: OTHER
- Collaborator: University Hospital, Antwerp
- Collaborator class: OTHER
- Collaborator: Universitair Ziekenhuis Brussel
- Collaborator class: OTHER
- Collaborator: General Hospital Groeninge
- Collaborator class: OTHER
- Collaborator: Vitaz
- Collaborator class: OTHER
- Collaborator: Centre Hospitalier Universitaire de Liege
- Collaborator class: OTHER
- Collaborator: Erasme University Hospital
- Collaborator class: OTHER
- Collaborator: Centre Hospitalier Mouscron
- Collaborator class: UNKNOWN
- Collaborator: Jan Yperman Ziekenhuis
- Collaborator class: OTHER
- Collaborator: AZ Turnhout
- Collaborator class: OTHER
- Collaborator: AZ Sint-Lucas Brugge
- Collaborator class: OTHER
- Collaborator: Ziekenhuis aan de Stroom
- Collaborator class: OTHER
- Collaborator: Onze Lieve Vrouw Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Universitaire Ziekenhuizen KU Leuven (`cardio:org-universitaire-ziekenhuizen-ku-leuven`)
- Registry lists this organization as a collaborator: University Hospital, Antwerp (`cardio:org-university-hospital-antwerp`)
- Registry lists this organization as a collaborator: Universitair Ziekenhuis Brussel (`cardio:org-universitair-ziekenhuis-brussel`)
- Registry lists this organization as a collaborator: Erasme University Hospital (`cardio:org-erasme-university-hospital`)
- Registry lists this organization as a collaborator: AZ Sint-Lucas Brugge (`cardio:org-az-sint-lucas-brugge`)
- Registry lists this organization as a collaborator: Onze Lieve Vrouw Hospital (`cardio:org-onze-lieve-vrouw-hospital`)

## Provenance

Content hash: 78899855f88e2109f3b5b2405b3009af2891925e55a3a46b45c80b75921b63dc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
